SEC Form 4 · accession 0001214659-18-002133
HUMANIGEN, INC · HGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron Durrant
Officer — Chief Executive Officer · Director
Period of report
Mar 9, 2018
Accepted (ET)
Mar 13, 2018 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293310
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.665 | Mar 9, 2018 | A | 7,466,749 | A | Mar 9, 2018 | Sep 12, 2026 | Common Stock | 7,466,749 | 8,509,771 | D |
Explanation of responses
- F1These stock options are intended to preserve the incentive offered to the executive in connection with his stock option granted on September 13, 2016, after giving effect to the dilution resulting from the completion of the Company's previously reported restructuring transaction on February 27, 2018. Accordingly, as of the filing date, the option is deemed vested as to one-half of the underlying shares, and the remainder vests in six quarterly installments commencing June 13, 2018.